{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:40:13Z","timestamp":1792514413093,"version":"4.5.0"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s40272-019-00327-9","type":"journal-article","created":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T02:48:29Z","timestamp":1557802109000},"page":"81-93","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Childhood-Onset Takayasu Arteritis (c-TA): Current and Future Drug Therapy"],"prefix":"10.1007","volume":"21","author":[{"given":"Ruchika","family":"Goel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Sathish Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debashish","family":"Danda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,13]]},"reference":[{"issue":"11","key":"327_CR1","doi-asserted-by":"publisher","first-page":"919","DOI":"10.7326\/0003-4819-120-11-199406010-00004","volume":"120","author":"GS Kerr","year":"1994","unstructured":"Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, Rottem M, et al. Takayasu arteritis. Ann Intern Med. 1994;120(11):919\u201329.","journal-title":"Ann Intern Med"},{"issue":"3 Suppl 82","key":"327_CR2","first-page":"S128","volume":"32","author":"G Clemente","year":"2014","unstructured":"Clemente G, Hilario MOE, Lederman H, Silva CA, Sallum AM, Campos LM, et al. Takayasu arteritis in a Brazilian multicenter study: children with a longer diagnosis delay than adolescents. Clin Exp Rheumatol. 2014;32(3 Suppl 82):S128\u201333.","journal-title":"Clin Exp Rheumatol"},{"key":"327_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1546-0096-12-21","volume":"12","author":"HS Szugye","year":"2014","unstructured":"Szugye HS, Zeft AS, Spalding SJ. Takayasu Arteritis in the pediatric population: a contemporary United States-based single center cohort. Pediatr Rheumatol Online J. 2014;12:21.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"10","key":"327_CR4","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1093\/rheumatology\/keq167","volume":"49","author":"J Brunner","year":"2010","unstructured":"Brunner J, Feldman BM, Tyrrell PN, Kuemmerle-Deschner JB, Zimmerhackl LB, Gassner I, et al. Takayasu arteritis in children and adolescents. Rheumatol Oxf Engl. 2010;49(10):1806\u201314.","journal-title":"Rheumatol Oxf Engl."},{"issue":"6","key":"327_CR5","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.3899\/jrheum.131117","volume":"41","author":"R Goel","year":"2014","unstructured":"Goel R, Kumar TS, Danda D, Joseph G, Jeyaseelan V, Surin AK, et al. Childhood-onset Takayasu arteritis\u2014experience from a tertiary care center in South India. J Rheumatol. 2014;41(6):1183\u20139.","journal-title":"J Rheumatol"},{"issue":"1","key":"327_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12969-017-0164-2","volume":"15","author":"Y Feng","year":"2017","unstructured":"Feng Y, Tang X, Liu M, Zhou J, Zhao X, Li Q. Clinical study of children with Takayasu arteritis: a retrospective study from a single center in China. Pediatr Rheumatol Online J. 2017;15(1):29.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"5","key":"327_CR7","first-page":"913","volume":"35","author":"N Cakar","year":"2008","unstructured":"Cakar N, Yalcinkaya F, Duzova A, Caliskan S, Sirin A, Oner A, et al. Takayasu arteritis in children. J Rheumatol. 2008;35(5):913\u20139.","journal-title":"J Rheumatol"},{"issue":"4","key":"327_CR8","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s00247-002-0817-1","volume":"33","author":"M McCulloch","year":"2003","unstructured":"McCulloch M, Andronikou S, Goddard E, Sinclair P, Lawrenson J, Mandelstam S, et al. Angiographic features of 26 children with Takayasu\u2019s arteritis. Pediatr Radiol. 2003;33(4):230\u20135.","journal-title":"Pediatr Radiol"},{"issue":"7","key":"327_CR9","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1136\/ard.2005.046300","volume":"65","author":"S Ozen","year":"2006","unstructured":"Ozen S, Ruperto N, Dillon MJ, Bagga A, Barron K, Davin JC, et al. EULAR\/PReS endorsed consensus criteria* for the classification of childhood vasculitides. Ann Rheum Dis. 2006;65(7):936\u201341.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"327_CR10","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1136\/ard.2009.116657","volume":"69","author":"S Ozen","year":"2010","unstructured":"Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, et al. EULAR\/PRINTO\/PRES criteria for Henoch\u2013Sch\u00f6nlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis. 2010;69(5):798\u2013806.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"327_CR11","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1002\/art.22404","volume":"56","author":"K Maksimowicz-McKinnon","year":"2007","unstructured":"Maksimowicz-McKinnon K, Clark TM, Hoffman GS. Limitations of therapy and a guarded prognosis in an american cohort of takayasu arteritis patients. Arthritis Rheum. 2007;56(3):1000\u20139.","journal-title":"Arthritis Rheum"},{"issue":"12","key":"327_CR12","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1161\/01.CIR.0000090689.69973.B1","volume":"108","author":"A Matsuyama","year":"2003","unstructured":"Matsuyama A, Sakai N, Ishigami M, Hiraoka H, Kashine S, Hirata A, et al. Matrix metalloproteinases as novel disease markers in Takayasu arteritis. Circulation. 2003;108(12):1469\u201373.","journal-title":"Circulation"},{"issue":"8","key":"327_CR13","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1007\/s00296-013-2937-3","volume":"34","author":"S Dogan","year":"2014","unstructured":"Dogan S, Piskin O, Solmaz D, Akar S, Gulcu A, Yuksel F, et al. Markers of endothelial damage and repair in Takayasu arteritis: are they associated with disease activity? Rheumatol Int. 2014;34(8):1129\u201338.","journal-title":"Rheumatol Int"},{"issue":"3 Suppl 97","key":"327_CR14","first-page":"S73","volume":"34","author":"F Alibaz-Oner","year":"2016","unstructured":"Alibaz-Oner F, Aksu K, Yentur SP, Keser G, Saruhan-Direskeneli G, Direskeneli H. Plasma pentraxin-3 levels in patients with Takayasu\u2019s arteritis during routine follow-up. Clin Exp Rheumatol. 2016;34(3 Suppl 97):S73\u20136.","journal-title":"Clin Exp Rheumatol"},{"issue":"16","key":"327_CR15","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1016\/j.jacc.2010.10.058","volume":"57","author":"T Ishihara","year":"2011","unstructured":"Ishihara T, Haraguchi G, Kamiishi T, Tezuka D, Inagaki H, Isobe M. Sensitive assessment of activity of Takayasu\u2019s arteritis by pentraxin3, a new biomarker. J Am Coll Cardiol. 2011;57(16):1712\u20133.","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"327_CR16","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1007\/s00296-017-3786-2","volume":"37","author":"AM Nair","year":"2017","unstructured":"Nair AM, Goel R, Hindhumati M, Jayakanthan K, Visalakshi J, Joseph G, et al. Serum amyloid A as a marker of disease activity and treatment response in Takayasu arteritis. Rheumatol Int. 2017;37(10):1643\u20139.","journal-title":"Rheumatol Int."},{"key":"327_CR17","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2174\/1874312901711010023","volume":"11","author":"R Goel","year":"2017","unstructured":"Goel R, Kabeerdoss J, Ram B, Prakash JAJ, Babji S, Nair A, et al. Serum Cytokine Profile in Asian Indian patients with Takayasu arteritis and its association with disease activity. Open Rheumatol J. 2017;11:23\u20139.","journal-title":"Open Rheumatol J"},{"issue":"2 Suppl 89","key":"327_CR18","first-page":"S32","volume":"33","author":"F Alibaz-Oner","year":"2015","unstructured":"Alibaz-Oner F, Yent\u00fcr SP, Saruhan-Direskeneli G, Direskeneli H. Serum cytokine profiles in Takayasu\u2019s arteritis: search for biomarkers. Clin Exp Rheumatol. 2015;33(2 Suppl 89):S32\u20135.","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"327_CR19","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/1756-185X.13027","volume":"21","author":"R Goel","year":"2018","unstructured":"Goel R, Kabeerdoss J, Mohan H, Danda S, Jayaseelan V, Kumar TS, et al. Soluble-HLA-E: a follow up biomarker in Takayasu arteritis, independent of HLA-E genotype. Int J Theuum Dis. 2018;21(2):532\u201340.","journal-title":"Int J Theuum Dis."},{"issue":"6","key":"327_CR20","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1186\/s13075-014-0479-z","volume":"16","author":"E Tombetti","year":"2014","unstructured":"Tombetti E, Di Chio MC, Sartorelli S, Papa M, Salerno A, Bottazzi B, et al. Systemic pentraxin-3 levels reflect vascular enhancement and progression in Takayasu arteritis. Arthritis Res Ther. 2014;16(6):479.","journal-title":"Arthritis Res Ther"},{"issue":"Suppl 1","key":"327_CR21","doi-asserted-by":"publisher","first-page":"S191","DOI":"10.1016\/S0167-5273(98)00181-8","volume":"66","author":"GS Hoffman","year":"1998","unstructured":"Hoffman GS, Ahmed AE. Surrogate markers of disease activity in patients with Takayasu arteritis. A preliminary report from The International Network for the Study of the Systemic Vasculitides (INSSYS). Int J Cardiol. 1998;66(Suppl 1):S191\u20134 (discussion S195).","journal-title":"Int J Cardiol"},{"issue":"4","key":"327_CR22","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1253\/circj.CJ-11-1108","volume":"76","author":"H Ohigashi","year":"2012","unstructured":"Ohigashi H, Haraguchi G, Konishi M, Tezuka D, Kamiishi T, Ishihara T, et al. Improved prognosis of Takayasu arteritis over the past decade. Circ J. 2012;76(4):1004\u201311.","journal-title":"Circ J"},{"issue":"2","key":"327_CR23","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s002700000368","volume":"24","author":"S Yoshida","year":"2001","unstructured":"Yoshida S, Akiba H, Tamakawa M, Yama N, Takeda M, Hareyama M, et al. The spectrum of findings in supra-aortic Takayasu\u2019s arteritis as seen on spiral CT angiography and digital subtraction angiography. Cardiovasc Intervent Radiol. 2001;24(2):117\u201321.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"6","key":"327_CR24","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1002\/art.10251","volume":"46","author":"E Tso","year":"2002","unstructured":"Tso E, Flamm SD, White RD, Schvartzman PR, Mascha E, Hoffman GS. Takayasu arteritis: utility and limitations of magnetic resonance imaging in diagnosis and treatment. Arthritis Rheum. 2002;46(6):1634\u201342.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"327_CR25","doi-asserted-by":"publisher","first-page":"e215","DOI":"10.1016\/j.lpm.2017.03.022","volume":"46","author":"E Tombetti","year":"2017","unstructured":"Tombetti E, Mason JC. Application of imaging techniques for Takayasu arteritis. Presse M\u00e9dicale. 2017;46(7):e215\u201323.","journal-title":"Presse M\u00e9dicale"},{"issue":"3","key":"327_CR26","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s10067-015-2885-2","volume":"35","author":"Y Sun","year":"2016","unstructured":"Sun Y, Ma L, Ji Z, Zhang Z, Chen H, Liu H, et al. Value of whole-body contrast-enhanced magnetic resonance angiography with vessel wall imaging in quantitative assessment of disease activity and follow-up examination in Takayasu\u2019s arteritis. Clin Rheumatol. 2016;35(3):685\u201393.","journal-title":"Clin Rheumatol"},{"issue":"Suppl 1","key":"327_CR27","doi-asserted-by":"publisher","first-page":"S85","DOI":"10.1016\/S0167-5273(98)00155-7","volume":"66","author":"BK Sharma","year":"1998","unstructured":"Sharma BK, Jain S, Radotra BD. An autopsy study of Takayasu arteritis in India. Int J Cardiol. 1998;66(Suppl 1):S85\u201390 (discussion S91).","journal-title":"Int J Cardiol"},{"issue":"1","key":"327_CR28","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/0167-5273(96)02660-5","volume":"55","author":"A Aggarwal","year":"1996","unstructured":"Aggarwal A, Chag M, Sinha N, Naik S. Takayasu\u2019s arteritis: role of Mycobacterium tuberculosis and its 65\u00a0kDa heat shock protein. Int J Cardiol. 1996;55(1):49\u201355.","journal-title":"Int J Cardiol"},{"key":"327_CR29","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/1471-2334-12-194","volume":"12","author":"ME Soto","year":"2012","unstructured":"Soto ME, Del Carmen \u00c1vila-Casado M, Huesca-G\u00f3mez C, Alarcon GV, Castrejon V, Soto V, et al. Detection of IS6110 and HupB gene sequences of Mycobacterium tuberculosis and bovis in the aortic tissue of patients with Takayasu\u2019s arteritis. BMC Infect Dis. 2012;12:194.","journal-title":"BMC Infect Dis"},{"issue":"9","key":"327_CR30","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.humimm.2006.06.003","volume":"67","author":"G Saruhan-Direskeneli","year":"2006","unstructured":"Saruhan-Direskeneli G, Bi\u00e7ak\u00e7igil M, Yilmaz V, Kamali S, Aksu K, Fresko I, et al. Interleukin (IL)-12, IL-2, and IL-6 gene polymorphisms in Takayasu\u2019s arteritis from Turkey. Hum Immunol. 2006;67(9):735\u201340.","journal-title":"Hum Immunol"},{"issue":"2","key":"327_CR31","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.ajhg.2013.05.024","volume":"93","author":"C Terao","year":"2013","unstructured":"Terao C, Yoshifuji H, Kimura A, Matsumura T, Ohmura K, Takahashi M, et al. Two susceptibility loci to Takayasu arteritis reveal a synergistic role of the IL12B and HLA-B regions in a Japanese population. Am J Hum Genet. 2013;93(2):289\u201397.","journal-title":"Am J Hum Genet"},{"issue":"2","key":"327_CR32","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.ajhg.2013.05.026","volume":"93","author":"G Saruhan-Direskeneli","year":"2013","unstructured":"Saruhan-Direskeneli G, Hughes T, Aksu K, Keser G, Coit P, Aydin SZ, et al. Identification of multiple genetic susceptibility loci in Takayasu arteritis. Am J Hum Genet. 2013;93(2):298\u2013305.","journal-title":"Am J Hum Genet"},{"key":"327_CR33","doi-asserted-by":"crossref","unstructured":"Renauer P, Saruhan-Direskeneli G, Coit P, Adler A, Aksu K, Keser G, et al. Genome-wide association study identifies susceptibility loci in IL6, RPS9\/LILRB3, and an intergenic locus on chromosome 21q22 in Takayasu\u2019s arteritis. Arthritis Rheumatol. 2015;n\/a \u2013 n\/a.","DOI":"10.1002\/art.39035"},{"issue":"7\u20138","key":"327_CR34","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.humimm.2017.04.008","volume":"78","author":"D Danda","year":"2017","unstructured":"Danda D, Goel R, Danda S, Mohan H, Joseph G, Kabeerdoss J, et al. Interleukin-17F and interleukin-6 gene polymorphisms in Asian Indian patients with Takayasu arteritis. Hum Immunol. 2017;78(7\u20138):515\u201320.","journal-title":"Hum Immunol"},{"issue":"1","key":"327_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MD.0b013e3181cba0a3","volume":"89","author":"L Arnaud","year":"2010","unstructured":"Arnaud L, Haroche J, Limal N, Toledano D, Gambotti L, Costedoat Chalumeau N, et al. Takayasu arteritis in France: a single-center retrospective study of 82 cases comparing white, North African, and black patients. Med (Baltimore). 2010;89(1):1\u201317.","journal-title":"Med (Baltimore)"},{"issue":"Suppl 1","key":"327_CR36","doi-asserted-by":"publisher","first-page":"S77","DOI":"10.1016\/S0167-5273(00)00194-7","volume":"75","author":"Y Seko","year":"2000","unstructured":"Seko Y, Takahashi N, Tada Y, Yagita H, Okumura K, Nagai R. Restricted usage of T-cell receptor Vgamma-Vdelta genes and expression of costimulatory molecules in Takayasu\u2019s arteritis. Int J Cardiol. 2000;75(Suppl 1):S77\u201383 (discussion S85\u20137).","journal-title":"Int J Cardiol"},{"issue":"1","key":"327_CR37","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.autrev.2011.08.001","volume":"11","author":"L Arnaud","year":"2011","unstructured":"Arnaud L, Haroche J, Mathian A, Gorochov G, Amoura Z. Pathogenesis of Takayasu\u2019s arteritis: a 2011 update. Autoimmun Rev. 2011;11(1):61\u20137.","journal-title":"Autoimmun Rev"},{"key":"327_CR38","doi-asserted-by":"crossref","unstructured":"Saadoun D, Garrido M, Comarmond C, Desbois AC, Domont F, Savey L, et al. Th1 and Th17 cytokines drive Takayasu Arteritis inflammation. Arthritis Rheumatol Hoboken NJ. 2015.","DOI":"10.1002\/art.39037"},{"key":"327_CR39","first-page":"7841718","volume":"2016","author":"DP Misra","year":"2016","unstructured":"Misra DP, Chaurasia S, Misra R. Increased circulating Th17 cells, serum IL-17A, and IL-23 in Takayasu arteritis. Autoimmune Dis. 2016;2016:7841718.","journal-title":"Autoimmune Dis"},{"issue":"2","key":"327_CR40","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1046\/j.1365-2249.2003.02282.x","volume":"134","author":"NK Tripathy","year":"2003","unstructured":"Tripathy NK, Sinha N, Nityanand S. Anti-annexin V antibodies in Takayasu\u2019s arteritis: prevalence and relationship with disease activity. Clin Exp Immunol. 2003;134(2):360\u20134.","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"327_CR41","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jvs.2010.06.173","volume":"53","author":"H Wang","year":"2011","unstructured":"Wang H, Ma J, Wu Q, Luo X, Chen Z, Kou L. Circulating B lymphocytes producing autoantibodies to endothelial cells play a role in the pathogenesis of Takayasu arteritis. J Vasc Surg. 2011;53(1):174\u201380.","journal-title":"J Vasc Surg"},{"issue":"1","key":"327_CR42","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1136\/ard.2011.153007","volume":"71","author":"BF Hoyer","year":"2012","unstructured":"Hoyer BF, Mumtaz IM, Loddenkemper K, Bruns A, Sengler C, Hermann K-G, et al. Takayasu arteritis is characterised by disturbances of B cell homeostasis and responds to B cell depletion therapy with rituximab. Ann Rheum Dis. 2012;71(1):75\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"8913","key":"327_CR43","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/S0140-6736(94)93103-8","volume":"343","author":"R Misra","year":"1994","unstructured":"Misra R, Aggarwal A, Chag M, Sinha N, Shrivastava S. Raised anticardiolipin antibodies in Takayasu\u2019s arteritis. Lancet Lond Engl. 1994;343(8913):1644\u20135.","journal-title":"Lancet Lond Engl"},{"issue":"4","key":"327_CR44","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1536\/ihj.16-533","volume":"58","author":"X Wang","year":"2017","unstructured":"Wang X, Dang A, Lv N, Cheng N, Cheng X. Inflammation Is Associated With Platelet Coagulation Function Rather Than Enzymatic Coagulation Function in Patients With Takayasu Arteritis. Int Heart J. 2017;58(4):589\u201392. \n                    https:\/\/doi.org\/10.1536\/ihj.16-533","journal-title":"Int Heart J."},{"issue":"6","key":"327_CR45","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.autrev.2016.02.012","volume":"15","author":"Y Ferfar","year":"2016","unstructured":"Ferfar Y, Mirault T, Desbois AC, Comarmond C, Messas E, Savey L, et al. Biotherapies in large vessel vasculitis. Autoimmun Rev. 2016;15(6):544\u201351.","journal-title":"Autoimmun Rev"},{"issue":"5","key":"327_CR46","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1093\/rheumatology\/ket320","volume":"53","author":"G Keser","year":"2014","unstructured":"Keser G, Direskeneli H, Aksu K. Management of Takayasu arteritis: a systematic review. Rheumatol Oxf Engl. 2014;53(5):793\u2013801.","journal-title":"Rheumatol Oxf Engl"},{"issue":"4","key":"327_CR47","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1161\/01.CIR.90.4.1855","volume":"90","author":"K Ishikawa","year":"1994","unstructured":"Ishikawa K, Maetani S. Long-term outcome for 120 Japanese patients with Takayasu\u2019s disease. Clinical and statistical analyses of related prognostic factors. Circulation. 1994;90(4):1855\u201360.","journal-title":"Circulation"},{"issue":"1 Suppl 70","key":"327_CR48","first-page":"S114","volume":"30","author":"I K\u00f6tter","year":"2012","unstructured":"K\u00f6tter I, Henes JC, Wagner AD, Loock J, Gross WL. Does glucocorticosteroid-resistant large-vessel vasculitis (giant cell arteritis and Takayasu arteritis) exist and how can remission be achieved? A critical review of the literature. Clin Exp Rheumatol. 2012;30(1 Suppl 70):S114\u201329.","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"327_CR49","first-page":"62","volume":"36","author":"X Kong","year":"2018","unstructured":"Kong X, Ma L, Ji Z, Dong Z, Zhang Z, Hou J, et al. Pro-fibrotic effect of IL-6 via aortic adventitial fibroblasts indicates IL-6 as a treatment target in Takayasu arteritis. Clin Exp Rheumatol. 2018;36(1):62\u201372.","journal-title":"Clin Exp Rheumatol."},{"issue":"3","key":"327_CR50","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.jjcc.2016.10.016","volume":"70","author":"N Tamura","year":"2017","unstructured":"Tamura N, Maejima Y, Tezuka D, Takamura C, Yoshikawa S, Ashikaga T, et al. Profiles of serum cytokine levels in Takayasu arteritis patients: Potential utility as biomarkers for monitoring disease activity. J Cardiol. 2017;70(3):278\u201385.","journal-title":"J Cardiol."},{"issue":"6","key":"327_CR51","doi-asserted-by":"publisher","first-page":"485","DOI":"10.5414\/CNP64485","volume":"64","author":"I K\u00f6tter","year":"2005","unstructured":"K\u00f6tter I, Daikeler T, Amberger C, Tyndall A, Kanz L. Autologous stem cell transplantation of treatment-resistant systemic vasculitis\u2013a single center experience and review of the literature. Clin Nephrol. 2005;64(6):485\u20139.","journal-title":"Clin Nephrol"},{"issue":"10","key":"327_CR52","first-page":"1370","volume":"16","author":"GC Liang","year":"1989","unstructured":"Liang GC, Nemickas R, Madayag M. Multiple percutaneous transluminal angioplasties and low dose pulse methotrexate for Takayasu\u2019s arteritis. J Rheumatol. 1989;16(10):1370\u20133.","journal-title":"J Rheumatol"},{"issue":"7","key":"327_CR53","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1136\/ard.51.7.904","volume":"51","author":"D Mevorach","year":"1992","unstructured":"Mevorach D, Leibowitz G, Brezis M, Raz E. Induction of remission in a patient with Takayasu\u2019s arteritis by low dose pulses of methotrexate. Ann Rheum Dis. 1992;51(7):904\u20135.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"327_CR54","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1002\/art.1780370420","volume":"37","author":"GS Hoffman","year":"1994","unstructured":"Hoffman GS, Leavitt RY, Kerr GS, Rottem M, Sneller MC, Fauci AS. Treatment of glucocorticoid-resistant or relapsing Takayasu arteritis with methotrexate. Arthritis Rheum. 1994;37(4):578\u201382.","journal-title":"Arthritis Rheum"},{"issue":"8","key":"327_CR55","first-page":"1793","volume":"30","author":"AK Valsakumar","year":"2003","unstructured":"Valsakumar AK, Valappil UC, Jorapur V, Garg N, Nityanand S, Sinha N. Role of immunosuppressive therapy on clinical, immunological, and angiographic outcome in active Takayasu\u2019s arteritis. J Rheumatol. 2003;30(8):1793\u20138.","journal-title":"J Rheumatol"},{"issue":"3","key":"327_CR56","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s10067-009-1333-6","volume":"29","author":"R Goel","year":"2010","unstructured":"Goel R, Danda D, Mathew J, Edwin N. Mycophenolate mofetil in Takayasu\u2019s arteritis. Clin Rheumatol. 2010;29(3):329\u201332.","journal-title":"Clin Rheumatol"},{"issue":"3","key":"327_CR57","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3109\/03009742.2011.633553","volume":"41","author":"AWS De Souza","year":"2012","unstructured":"De Souza AWS, da Silva MD, Machado LSG, Oliveira ACD, Pinheiro FAG, Sato EI. Short-term effect of leflunomide in patients with Takayasu arteritis: an observational study. Scand J Rheumatol. 2012;41(3):227\u201330.","journal-title":"Scand J Rheumatol"},{"key":"327_CR58","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.rbr.2015.09.007","volume":"56","author":"AWS De Souza","year":"2016","unstructured":"De Souza AWS, de Almeida Agustinelli R, de Cinque Almeida H, Oliveira PB, Pinheiro FAG, Oliveira ACD, et al. Leflunomide in Takayasu arteritis\u2014a long term observational study. Rev Bras Reumatol. 2016;56:371\u20135.","journal-title":"Rev Bras Reumatol"},{"issue":"11","key":"327_CR59","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1001\/archderm.1991.01680100135027","volume":"127","author":"SH Fullerton","year":"1991","unstructured":"Fullerton SH, Abel EA, Getz K, El-Ramahi K. Cyclosporine treatment of severe recalcitrant pyoderma gangrenosum in a patient with Takayasu\u2019s arteritis. Arch Dermatol. 1991;127(11):1731\u20132.","journal-title":"Arch Dermatol"},{"issue":"4","key":"327_CR60","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/j.1365-2230.2004.01514.x","volume":"29","author":"H Ujiie","year":"2004","unstructured":"Ujiie H, Sawamura D, Yokota K, Nishie W, Shichinohe R, Shimizu H. Pyoderma gangrenosum associated with Takayasu\u2019s arteritis. Clin Exp Dermatol. 2004;29(4):357\u20139.","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"327_CR61","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1046\/j.1365-2133.1999.02989.x","volume":"141","author":"LA Fearfield","year":"1999","unstructured":"Fearfield LA, Ross JR, Farrell AM, Costello C, Bunker CB, Staughton RC. Pyoderma gangrenosum associated with Takayasu\u2019s arteritis responding to cyclosporin. Br J Dermatol. 1999;141(2):339\u201343.","journal-title":"Br J Dermatol"},{"issue":"22","key":"327_CR62","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.2169\/internalmedicine.46.0211","volume":"46","author":"I Yokoe","year":"2007","unstructured":"Yokoe I, Haraoka H, Harashima H. A patient with Takayasu\u2019s arteritis and rheumatoid arthritis who responded to tacrolimus hydrate. Intern Med Tokyo Jpn. 2007;46(22):1873\u20137.","journal-title":"Intern Med Tokyo Jpn"},{"issue":"1","key":"327_CR63","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/BOR.0000000000000004","volume":"26","author":"A Clifford","year":"2014","unstructured":"Clifford A, Hoffman GS. Recent advances in the medical management of Takayasu arteritis: an update on use of biologic therapies. Curr Opin Rheumatol. 2014;26(1):7\u201315.","journal-title":"Curr Opin Rheumatol"},{"issue":"18","key":"327_CR64","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1161\/CIRCULATIONAHA.114.014321","volume":"132","author":"A Mekinian","year":"2015","unstructured":"Mekinian A, Comarmond C, Resche-Regon M, Mirault T, Kahn JE, Lambert M, et al. Efficacy of biological-targeted treatments in takayasu arteritis: multicenter retrospective study of 49 patients. Circulation. 2015;132(18):1693\u2013700.","journal-title":"Circulation."},{"issue":"12","key":"327_CR65","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.autrev.2013.06.019","volume":"12","author":"N Abisror","year":"2013","unstructured":"Abisror N, Mekinian A, Lavigne C, Vandenhende M-A, Soussan M, Fain O, et al. Tocilizumab in refractory Takayasu arteritis: a case series and updated literature review. Autoimmun Rev. 2013;12(12):1143\u20139.","journal-title":"Autoimmun Rev"},{"issue":"7","key":"327_CR66","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1093\/rheumatology\/kex249","volume":"57","author":"G Pazzola","year":"2017","unstructured":"Pazzola G, Muratore F, Pipitone N, Crescentini F, Cacoub P, Boiardi L, et al. Rituximab therapy for Takayasu arteritis: a seven patients experience and a review of the literature. Rheumatology (Oxford). 2017;57(7):1151\u20135. \n                    https:\/\/doi.org\/10.1093\/rheumatology\/kex249","journal-title":"Rheumatology (Oxford)."},{"issue":"4","key":"327_CR67","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/art.40037","volume":"69","author":"CA Langford","year":"2017","unstructured":"Langford CA, Cuthbertson D, Ytterberg SR, Khalidi N, Monach PA, Carette S, et al. A randomized, double-blind trial of abatacept (CTLA-4Ig) for the treatment of Takayasu arteritis. Arthritis Rheumatol Hoboken NJ. 2017;69(4):846\u201353.","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"issue":"Suppl 2","key":"327_CR68","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1136\/annrheumdis-2015-eular.4170","volume":"74","author":"C Terao","year":"2015","unstructured":"Terao C, Yoshifuji H, Yukawa N, Nakajima T, Matsuda F, Mimori T. AB0636 Ustekinumab as a therapeutic option for Takayasu arteritis\u2014from genetic findings to clinical application. Ann Rheum Dis. 2015;74(Suppl 2):1111\u20132.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"327_CR69","doi-asserted-by":"publisher","first-page":"506","DOI":"10.3109\/03009741003742730","volume":"39","author":"LH Jales-Neto","year":"2010","unstructured":"Jales-Neto LH, Levy-Neto M, Bonfa E, de Carvalho JF, Pereira RMR. Juvenile-onset Takayasu arteritis: peculiar vascular involvement and more refractory disease. Scand J Rheumatol. 2010;39(6):506\u201310.","journal-title":"Scand J Rheumatol"},{"issue":"2","key":"327_CR70","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.40690","volume":"71","author":"FA Aeschlimann","year":"2019","unstructured":"Aeschlimann FA, Barra L, Alsolaimani R, Benseler SM, Hebert D, Khalidi N, et al. Presentation and disease course of childhood- versus adult-onset Takayasu Arteritis. Arthritis Rheumatol. 2019;71(2):315\u201323.","journal-title":"Arthritis Rheumatol."},{"issue":"1","key":"327_CR71","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/1756-185X.13425","volume":"22","author":"S Sahin","year":"2019","unstructured":"Sahin S, Hopurcuoglu D, Bektas S, Belhan E, Adrovic A, Barut K, et al. Childhood-onset Takayasu arteritis: a 15-year experience from a tertiary referral center. Int J Rheum Dis. 2019;22(1):132\u201339.","journal-title":"Int J Rheum Dis."},{"issue":"75 Suppl 1","key":"327_CR72","doi-asserted-by":"publisher","first-page":"S153","DOI":"10.1016\/S0167-5273(00)00180-7","volume":"31","author":"S Jain","year":"2000","unstructured":"Jain S, Sharma N, Singh S, Bali HK, Kumar L, Sharma BK. Takayasu arteritis in children and young indians. Int J Cardiol. 2000;31(75 Suppl 1):S153\u20137.","journal-title":"Int J Cardiol"},{"issue":"7","key":"327_CR73","first-page":"1081","volume":"18","author":"E Morales","year":"1991","unstructured":"Morales E, Pineda C, Mart\u00ednez-Lav\u00edn M. Takayasu\u2019s arteritis in children. J Rheumatol. 1991;18(7):1081\u20134.","journal-title":"J Rheumatol"},{"issue":"1","key":"327_CR74","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jpeds.2006.10.059","volume":"150","author":"S Ozen","year":"2007","unstructured":"Ozen S, Duzova A, Bakkaloglu A, Bilginer Y, Cil BE, Demircin M, et al. Takayasu arteritis in children: preliminary experience with cyclophosphamide induction and corticosteroids followed by methotrexate. J Pediatr. 2007;150(1):72\u20136.","journal-title":"J Pediatr"},{"issue":"10","key":"327_CR75","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1007\/s00296-015-3272-7","volume":"35","author":"DP Misra","year":"2015","unstructured":"Misra DP, Aggarwal A, Lawrence A, Agarwal V, Misra R. Pediatric-onset Takayasu\u2019s arteritis: clinical features and short-term outcome. Rheumatol Int. 2015;35(10):1701\u20136.","journal-title":"Rheumatol Int"},{"issue":"17","key":"327_CR76","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13075-015-0545-1","volume":"25","author":"D Eleftheriou","year":"2015","unstructured":"Eleftheriou D, Varnier G, Dolezalova P, McMahon A-M, Al-Obaidi M, Brogan PA. Takayasu arteritis in childhood: retrospective experience from a tertiary referral centre in the United Kingdom. Arthritis Res Ther. 2015;25(17):36.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"327_CR77","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12969-016-0115-3","volume":"14","author":"FA Aeschlimann","year":"2016","unstructured":"Aeschlimann FA, Grosse-Wortmann L, Benseler SM, Laxer RM, Hebert D, Yeung RSM. Arterial dissection in childhood Takayasu Arteritis: not as rare as thought. Pediatr Rheumatol Online J. 2016;14(1):56.","journal-title":"Pediatr Rheumatol Online J."},{"issue":"4","key":"327_CR78","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.semarthrit.2016.07.012","volume":"46","author":"ED Batu","year":"2017","unstructured":"Batu ED, S\u00f6nmez HE, Haz\u0131rolan T, \u00d6zalt\u0131n F, Bilginer Y, \u00d6zen S. Tocilizumab treatment in childhood Takayasu arteritis: case series of four patients and systematic review of the literature. Semin Arthritis Rheum. 2017;46(4):529\u201335.","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"327_CR79","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.jpeds.2008.04.049","volume":"153","author":"G Filocamo","year":"2008","unstructured":"Filocamo G, Buoncompagni A, Viola S, Loy A, Malattia C, Ravelli A, et al. Treatment of Takayasu\u2019s arteritis with tumor necrosis factor antagonists. J Pediatr. 2008;153(3):432\u20134.","journal-title":"J Pediatr"},{"issue":"1","key":"327_CR80","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00296-009-1147-5","volume":"31","author":"PS Buonuomo","year":"2011","unstructured":"Buonuomo PS, Bracaglia C, Campana A, Insalaco A, Pardeo M, Cortis E, et al. Infliximab therapy in pediatric Takayasu\u2019s arteritis: report of two cases. Rheumatol Int. 2011;31(1):93\u20135.","journal-title":"Rheumatol Int"},{"issue":"4","key":"327_CR81","first-page":"183","volume":"20","author":"S Stern","year":"2014","unstructured":"Stern S, Clemente G, Reiff A, Ramos MPR, Marzan KA, Terreri MT. Treatment of pediatric Takayasu arteritis with infliximab and cyclophosphamide: experience from an American\u2013Brazilian cohort study. J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis. 2014;20(4):183\u20138.","journal-title":"J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis"},{"issue":"2","key":"327_CR82","first-page":"22","volume":"62","author":"I Malci\u0107","year":"2015","unstructured":"Malci\u0107 I, Detoni P, Kniewald H, Bartonicek D, Dilber D, Dietrich D, et al. Takayasu arteritis and possible cardiology repercussions in the childhood. Reumatizam. 2015;62(2):22\u20136.","journal-title":"Reumatizam"},{"issue":"9","key":"327_CR83","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1136\/ard.2005.047498","volume":"65","author":"E Seyahi","year":"2006","unstructured":"Seyahi E, Ugurlu S, Cumali R, Balci H, Seyahi N, Yurdakul S, et al. Atherosclerosis in Takayasu arteritis. Ann Rheum Dis. 2006;65(9):1202\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"327_CR84","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1536\/ihj.16-533","volume":"58","author":"X Wang","year":"2017","unstructured":"Wang X, Dang A, Lv N, Cheng N, Cheng X. Inflammation Is associated with platelet coagulation function rather than enzymatic coagulation function in patients with Takayasu arteritis. Int Heart J. 2017;58(4):589\u201392.","journal-title":"Int Heart J"},{"issue":"3","key":"327_CR85","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3109\/03009742.2014.964305","volume":"44","author":"NP Jordan","year":"2015","unstructured":"Jordan NP, Bezanahary H, D\u2019Cruz DP. Increased risk of vascular complications in Takayasu\u2019s arteritis patients with positive lupus anticoagulant. Scand J Rheumatol. 2015;44(3):211\u20134.","journal-title":"Scand J Rheumatol"},{"issue":"3","key":"327_CR86","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3899\/jrheum.121073","volume":"40","author":"AWS De Souza","year":"2013","unstructured":"De Souza AWS, De Lima CS, Oliveira ACD, Machado LSG, Pinheiro FAG, Hix S, et al. Homocysteine levels in Takayasu arteritis\u2014a risk factor for arterial ischemic events. J Rheumatol. 2013;40(3):303\u20138.","journal-title":"J Rheumatol"},{"issue":"6","key":"327_CR87","first-page":"1236","volume":"74","author":"AWS De Souza","year":"2010","unstructured":"De Souza AWS, Machado NP, Pereira VM, Arraes AED, Reis Neto ET, Mariz HA, et al. Antiplatelet therapy for the prevention of arterial ischemic events in Takayasu arteritis. Circ J Off J Jpn Circ Soc. 2010;74(6):1236\u201341.","journal-title":"Circ J Off J Jpn Circ Soc"},{"issue":"6","key":"327_CR88","first-page":"1079","volume":"74","author":"M Ueno","year":"2010","unstructured":"Ueno M. Antiplatelet therapy in the treatment of Takayasu arteritis. Circ J Off J Jpn Circ Soc. 2010;74(6):1079\u201380.","journal-title":"Circ J Off J Jpn Circ Soc."},{"issue":"5","key":"327_CR89","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1093\/rheumatology\/ket320","volume":"53","author":"G Keser","year":"2014","unstructured":"Keser G, Direskeneli H, Aksu K. Management of Takayasu arteritis: a systematic review. Rheumatol Oxf Engl. 2014;53(5):793\u2013801.","journal-title":"Rheumatol Oxf Engl"},{"issue":"2","key":"327_CR90","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/bjs.9372","volume":"101","author":"AH Perera","year":"2014","unstructured":"Perera AH, Youngstein T, Gibbs RGJ, Jackson JE, Wolfe JH, Mason JC. Optimizing the outcome of vascular intervention for Takayasu arteritis. Br J Surg. 2014;101(2):43\u201350.","journal-title":"Br J Surg"},{"issue":"12","key":"327_CR91","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nrrheum.2013.161","volume":"9","author":"CM Weyand","year":"2013","unstructured":"Weyand CM, Goronzy JJ. Immune mechanisms in medium and large-vessel vasculitis. Nat Rev Rheumatol. 2013;9(12):731\u201340.","journal-title":"Nat Rev Rheumatol"},{"issue":"399","key":"327_CR92","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.1126\/scitranslmed.aal3322","volume":"9","author":"Z Wen","year":"2017","unstructured":"Wen Z, Shen Y, Berry G, Shahram F, Li Y, Watanabe R, et al. The microvascular niche instructs T cells in large vessel vasculitis via the VEGF-Jagged1-Notch pathway. Sci Transl Med. 2017;9(399):3322.","journal-title":"Sci Transl Med"},{"issue":"3","key":"327_CR93","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1161\/CIRCULATIONAHA.110.936203","volume":"123","author":"K Piggott","year":"2011","unstructured":"Piggott K, Deng J, Warrington K, Younge B, Kubo JT, Desai M, et al. Blocking the NOTCH pathway inhibits vascular inflammation in large-vessel vasculitis. Circulation. 2011;123(3):309\u201318.","journal-title":"Circulation"},{"issue":"6","key":"327_CR94","doi-asserted-by":"publisher","first-page":"485","DOI":"10.5414\/CNP64485","volume":"64","author":"I K\u00f6tter","year":"2005","unstructured":"K\u00f6tter I, Daikeler T, Amberger C, Tyndall A, Kanz L. Autologous stem cell transplantation of treatment-resistant systemic vasculitis\u2013a single center experience and review of the literature. Clin Nephrol. 2005;64(6):485\u20139.","journal-title":"Clin Nephrol"},{"issue":"3 Suppl 97","key":"327_CR95","first-page":"S21","volume":"34","author":"X Kong","year":"2016","unstructured":"Kong X, Sun Y, Ma L, Chen H, Wei L, Wu W, et al. The critical role of IL-6 in the pathogenesis of Takayasu arteritis. Clin Exp Rheumatol. 2016;34(3 Suppl 97):S21\u20137.","journal-title":"Clin Exp Rheumatol"},{"key":"327_CR96","unstructured":"Comparison of Mycophenolate Mofetil and Cyclophosphamide for Active Takayasu\u2019s Arteritis\u2014Full Text View\u2014ClinicalTrials.gov [Internet]. \n                    https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03096275\n                    \n                  . Accessed 22 Dec 2018."}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-019-00327-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40272-019-00327-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-019-00327-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T23:43:21Z","timestamp":1589240601000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40272-019-00327-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":96,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["327"],"URL":"https:\/\/doi.org\/10.1007\/s40272-019-00327-9","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"13 May 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"RG, TSK, and DD have no conflicts of interest that are directly relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No sources of funding were used to conduct this study or prepare this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}}]}}